Diamond Pharma Services
Diamond Pharma Services is a leading technical and scientific consulting group serving the biotechnology and pharmaceutical industry. Our emphasis is on the following areas:
- Regulatory Affairs: From Product Concept to Registration and Beyond
- Product Development: Nonclinical, CMC and Clinical Aspects
- Pharmacovigilance: Clinical trial (Phase I-IV), Post-Marketing and QPPV Services
- Compliance: GLP, GMP, GCP and QP Services
- Patient Information Leaflet Testing: Over 120 Tested with 100% Positive Agency Feedback
Our clients range from virtual start-up companies to the largest multi-national corporations. Our expertise includes products of recombinant DNA and hybridoma technology, nucleotide based products (RNA and DNA), synthetic peptides, chemical entities (innovative and generic), vaccines (therapeutic and prophylactic), blood products and advanced therapy medicinal products (gene therapy products).
We have sophisticated and well-equipped office facilities and a state-of-the-art IT system. Our IT system includes a fully validated in-house eCTD system (Extedo) and safety database (ARISg). The company was founded in 2005 by Dr. Maureen Graham, formerly Director of Regulatory Affairs at Amgen. Our specialised team of more than 24 professionals includes those with a broad and varied industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit.
Mr Paul Cronin
The ERA Consulting Group is one of the longest established and most experienced regulatory affairs and product development consulting groups serving the biopharmaceutical industry.
Our expertise covers quality, nonclinical and clinical aspects, both from the regulatory and development strategy perspective. ERA has the knowledge and experience to assist from conception to registration, and beyond.
ERA has experience with a wide range of products (over 450 to date), including recombinant DNA and hybridoma technology, synthetic peptides, conventional and advanced vaccines, classical blood products, advanced therapy medicinal products comprising gene therapy, somatic cell therapy and tissue-engineered products. ERA also works with innovative new chemical entities, particularly those indicated for neurological, oncological and immunological diseases.
Our specialised international team of more than 30 full-time professionals includes scientists with a research and development background, those with extensive industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit.
ERA currently has four office locations (Germany, the UK, the USA and Australia), with the in-house capability to prepare documents and complete submissions on behalf of clients, including a dedicated eCTD group.
Mr. Tristan Elliott
Business Development Manager
Tel: +44(0)20 7510 0200
Mr Tristan ElliottBusiness Development Manager
Dr Christopher Holloway
Integrity Life Sciences
Providing Business Services and Consultancy to the Health Care and Life Sciences sectors.
Predominantly working with smaller biotech/pharma companies (including academic spin outs) and smaller health care charities.